Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

Author： Dalmau J Gultekin SH Voltz R Hoard R DesChamps T Balmaceda C Batchelor T Gerstner E Eichen J Frennier J Posner JB Rosenfeld MR

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.122, Iss.1, 1999-01, pp. : 27-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuron-specific enolase in patients with neurocysticercosis

By Lima J.E. Takayanagui O.M. Garcia L.V. Leite J.P.

Journal of the Neurological Sciences, Vol. 217, Iss. 1, 2004-01 ,pp. : 31-35

Elsevier

Access to resources Recommend Favorite

FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes

By Younes-Mhenni S.

Brain, Vol. 127, Iss. 10, 2004-10 ,pp. : 2331-2338

Oxford University Press

Access to resources Recommend Favorite

S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients

By Raabe Andreas Kopetsch Olaf Woszczyk Alina Lang Josef Gerlach Rüdiger Zimmermann Michael Seifert Volker

Neurological Research, Vol. 26, Iss. 4, 2004-06 ,pp. : 440-445

Maney Publishing

Access to resources Recommend Favorite

The role of [ 18 F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders

By Rees J.H.

Brain, Vol. 124, Iss. 11, 2001-11 ,pp. : 2223-2231

Oxford University Press

Access to resources Recommend Favorite

Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope

By Lee Seung-Yeob Choi Young-Chul Kim Jeong-Ho Kim Won-Joo

Journal of Neurology, Vol. 257, Iss. 10, 2010-10 ,pp. : 1708-1712

Springer Publishing Company

Access to resources Recommend Favorite